Reset filters
  • 24 April 2017

Generic hepatitis C drugs continue to produce high cure rates

Read the article
James Freeman at the International Liver Congress. Photo by Liz Highleyman, hivandhepatitis.com
  • 21 April 2017

AbbVie combination cures 95% of genotype 3 hepatitis C

Read the article
Graham Foster at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 21 April 2017

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

Read the article
Xavier Forns at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 21 April 2017

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

Read the article
Gregory Dore at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 20 April 2017

European HCV treatment access survey shows big variations in eligibility

Read the article
  • 20 April 2017

Curing hepatitis C reduces cardiovascular risk

Read the article
  • 19 April 2017

Hepatitis C treatment can be provided successfully at syringe programme sites

Read the article
  • 10 March 2017

Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals

Read the article
  • 8 March 2017

DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.